Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Adaptive Biotechnologies Corporation - SIC # -
Ticker
Exchange
SIC #
Website
Latest Ticker
ADPT
Nasdaq
www.adaptivebiotech.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Touts clonoSEQ MRD Growth, Targets Companywide Profitability in 2026
- Jan 12th, 2026 7:06 pm
Adaptive Biotechnologies Announces Preliminary Fourth Quarter and Full Year 2025 Results
- Jan 12th, 2026 5:30 am
Adaptive Biotechnologies to Present at the 44th Annual J.P. Morgan Healthcare Conference
- Dec 30th, 2025 2:05 pm
Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer
- Dec 15th, 2025 6:00 am
How Investors Are Reacting To Adaptive Biotechnologies (ADPT) clonoSEQ Data Shaping MRD-Guided Cancer Care
- Dec 15th, 2025 4:07 am
Leading Multiple Myeloma Results Unveiled at ASH 2025: Paradigm-Shifting Data Redefines Treatment Landscape | DelveInsight
- Dec 11th, 2025 3:31 pm
Adaptive Biotechnologies to Participate in Jefferies Fireside Chat Series on Minimal Residual Disease
- Dec 9th, 2025 3:07 pm
Adaptive Biotechnologies (ADPT) Falls 24.5% as Execs Dispose Millions of Stake
- Dec 8th, 2025 12:16 am
Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting
- Dec 6th, 2025 6:30 am
Assessing Adaptive Biotechnologies (ADPT) Valuation After a 179% One-Year Rebound and Recent Pullback
- Dec 3rd, 2025 8:18 pm
Future in Tech Appoints Ed Moyle as Chief Information Security Officer
- Dec 2nd, 2025 7:00 am
Adaptive Biotechnologies Announces Nearly 90 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 67th ASH Annual Meeting
- Nov 24th, 2025 5:30 am
Adaptive Biotechnologies (ADPT) Hits 3-Year High. Here’s Why
- Nov 22nd, 2025 8:10 am
Continued Momentum Lifted Adaptive Biotechnologies Corporation (ADPT) in Q3
- Nov 17th, 2025 7:05 am
Adaptive Biotechnologies (ADPT) Surges to First Profit and Lifts Guidance—Has the Investment Case Evolved?
- Nov 6th, 2025 11:25 pm
Adaptive Biotechnologies to Participate in Upcoming Investor Conferences
- Nov 6th, 2025 2:05 pm
Cathie Wood Loads Up Pinterest After Sell-Off -- Dumps Shopify, Roku, and Robinhood
- Nov 6th, 2025 5:05 am
Adaptive Biotechnologies Corp (ADPT) Q3 2025 Earnings Call Highlights: Record Revenue Growth ...
- Nov 5th, 2025 10:03 pm
Adaptive Biotechnologies (ADPT) Reports Q3 Earnings: What Key Metrics Have to Say
- Nov 5th, 2025 5:30 pm
Adaptive Biotechnologies (ADPT) Reports Q3 Loss, Beats Revenue Estimates
- Nov 5th, 2025 4:35 pm
Scroll